Acute lymphoblastic leukemia (ALL) is the most common cancer in children. For families facing a relapse after chemotherapy or bone marrow transplant, the search for hope can feel overwhelming. In recent years, CAR-T therapy for relapsed leukemia in children has changed the outlook, offering a new way to fight the disease using the child’s own immune system.
CAR-T (chimeric antigen receptor T-cell) therapy works by collecting a child’s T-cells, engineering them to recognize and attack leukemia cells, and then infusing them back. This highly personalized treatment has shown remarkable promise, with the success rate of pediatric CAR-T therapy improving year after year in international studies.
Among the best hospitals for pediatric CAR-T therapy, Sheba Medical Center in Israel stands out as a global leader. Known as one of the top 10 hospitals worldwide, Sheba combines advanced science with compassionate, family-centered care. The hospital’s pediatric hematology and oncology team has treated numerous international patients with CAR-T, including those who had no other options.
Families also find Sheba to be an affordable CAR-T therapy for kids compared to prices in the United States or Western Europe. Short waiting times, transparent protocols, and Israel’s reputation for medical innovation make it an attractive choice for medical tourism.
For parents searching for cutting-edge treatments that give their child the best chance, Sheba’s CAR-T program offers both medical excellence and hope.
Links
Initiating your CAR-T medical inquiry >>
CAR-T cell therapy in Sheba hospital in Israel
CAR-T cell therapy in Hadassah hospital in Israel
